公开(公告)号：KR101327318B1

公开(公告)日：2013-11-11

申请号：KR1020110037820

申请日：2011-04-22

Applicant: 한국화학연구원 ,  국민대학교산학협력단

Inventor： 최상운 ,  최춘환 ,  유시용 ,  김영섭 ,  차미란 ,  김민진 ,  전정희 ,  김영균

IPC: A61K31/343 ,  A61K36/882 ,  A61P35/00

Abstract: 본 발명은 노랑꽃창포(
Iris

pseudacorus ) 종자 추출물 및 이로부터 분리 정제된 레스베라트롤 화합물인 아이리스페린 A(irisferin A), 아이리스페린 B(irisferin B), 아이리스페린 C(irisferin C) 및 이들의 혼합물로 이루어진 그룹으로부터 선택된 어느 하나를 약제학적으로 허용되는 담체와 함께 함유하는 항암제 조성물에 관한 것으로, 본 발명의 조성물은 폐암, 난소암, 흑색종, 중추신경계암, 결장암, 백혈병 등 각종 악성종양의 예방 및 치료제로 사용될 수 있다.

公开(公告)号：KR1020120119693A

公开(公告)日：2012-10-31

申请号：KR1020110037820

申请日：2011-04-22

Applicant: 한국화학연구원 ,  국민대학교산학협력단

Inventor： 최상운 ,  최춘환 ,  유시용 ,  김영섭 ,  차미란 ,  김민진 ,  전정희 ,  김영균

IPC: A61K31/343 ,  A61K36/882 ,  A61P35/00

Abstract: PURPOSE: An anticancer drug composition which includes resveratrol derivative compound separated from iris tectorum seeds is provided to be used as therapeutic agent for various malign tumors. CONSTITUTION: An anticancer drug composition contains irisferin A, irisferin B, irisferin C, a pharmaceutically acceptable salt, isomer or a mixture thereof, or iris pseudacorus seed extract including the same as an active ingredient. The iris pseudacorus seed extract is obtained by extracting the iris pseudacorus seed with methanol, methanol aqueous solution, ethanol, ethanol water solution, butanol, dichloromethane, ethyl acetate or a mixture thereof. The cancer is lung cancer, ovarian cancer, melanoma, central nervous system cancer or colon carcinoma. A health supplement having the anti-cancer cell growth obstruction efficacy is irisferin A, irisferin B, irisferin C, a pharmaceutically acceptable salt, isomer or a mixture thereof, or iris pseudacorus seed extract including the same.

Abstract translation: 目的：提供一种抗癌药物组合物，其中包括从虹膜花粉种子分离的白藜芦醇衍生物，用作各种恶性肿瘤的治疗剂。 构成：抗癌药物组合物含有虹膜蛋白A，虹膜蛋白B，虹膜蛋白C，其药学上可接受的盐，异构体或其混合物，或包含其作为活性成分的虹膜假科种子提取物。 通过用甲醇，甲醇水溶液，乙醇，乙醇水溶液，丁醇，二氯甲烷，乙酸乙酯或其混合物提取虹膜假科种获得虹膜假科种子提取物。 癌症是肺癌，卵巢癌，黑素瘤，中枢神经系统癌或结肠癌。 具有抗癌细胞生长阻塞功效的健康补充剂是虹膜蛋白A，虹膜蛋白B，虹膜蛋白C，其药学上可接受的盐，异构体或其混合物，或包含其的虹膜假科种子提取物。

公开(公告)号：KR101830222B1

公开(公告)日：2018-02-22

申请号：KR1020110033674

申请日：2011-04-12

Applicant: 한국화학연구원 ,  국민대학교산학협력단

Inventor： 최상운 ,  유시용 ,  김영섭 ,  최춘환 ,  최연희 ,  차미란 ,  김영균

IPC: A61K31/045 ,  A61K31/05 ,  A61K36/87 ,  A23L33/10 ,  A23L33/105 ,  A23L2/52

Abstract: 본발명은포도() 줄기껍질추출물및 이로부터분리정제된레스베라트롤화합물인비티시놀 C(vitisinol C), 비티시놀 E(vitisinol E), 시스-비티신 A(cis-vitisin A), 비티신 B(vitisin B), 비티신 C(vitisin C) 및이들의혼합물로이루어진그룹으로부터선택된어느하나를약제학적으로허용되는담체와함께함유하는항암제조성물에관한것으로, 본발명의조성물은폐암, 난소암, 흑색종, 중추신경계종양, 결장암, 백혈병등 각종악성종양의예방및 치료제로사용될수 있다.

Abstract translation: 本发明涉及干细胞树皮提取物和从其中分离出的白藜芦醇化合物，例如葡萄糖醇C，葡萄素醇E，顺式 - 葡萄素A， 葡萄干素B，葡萄干素C及其混合物以及药学上可接受的载体，其中本发明的组合物是包含肺癌，卵巢癌， 可用作癌症，中枢神经系统肿瘤，结肠癌和白血病等各种恶性肿瘤的预防和治疗剂。

公开(公告)号：KR1020120116115A

公开(公告)日：2012-10-22

申请号：KR1020110033674

申请日：2011-04-12

Applicant: 한국화학연구원 ,  국민대학교산학협력단

Inventor： 최상운 ,  유시용 ,  김영섭 ,  최춘환 ,  최연희 ,  차미란 ,  김영균

IPC: A61K31/045 ,  A61K31/05 ,  A61K36/87 ,  A23L33/10 ,  A23L33/105 ,  A23L2/52

CPC classification number: A61K31/045 ,  A23L2/52 ,  A23L33/10 ,  A23L33/105 ,  A61K31/05 ,  A61K36/87 ,  A61K2300/00

Abstract: PURPOSE: An anticancer drug composition including resveratrol derivative compound separated from grape stem shell is provided to prevent and treat all kinds of cancers including lung cancer, ovarian cancer, melanoma, central nervous system tumor, colon carcinoma, and leukemia. CONSTITUTION: An anticancer drug composition includes vitisinol C, vitisinol E, cis-vitisin A, vitisin B, vitisin C, a pharmaceutically acceptable salt and isomer or a mixture thererof, and grape stem shell extract including thereof as an active ingredient. The grape stem shell extract is obtained by extracting methanol, methanol aqueous solution, ethanol, ethanol aqueous solution, butanol, dichloromethane, ethyl acetate or a mixture thereof. The cancer is lung cancer, ovarian cancer, melanoma or colon carcinoma. A health enhancement food having cancer cell growth inhibition efficacy contains vitisinol C, vitisinol E, cis-viticin A, viticin B, viticin C, pharmaceutically acceptable salt, isomer or a mixture thereof, and grapes stem shell extract including the same. The food is in beverage form. The grape stem shell extract is obtained by the following steps: extracting the grape stem shell by methanol and suspending the obtained extract in distilled water; partitioning thereof by dichloromethane; and extracting the obtained water layer by ethyl acetate.

Abstract translation: 目的：提供包括从葡萄茎壳分离的白藜芦醇衍生物化合物的抗癌药物组合物，用于预防和治疗各种癌症，包括肺癌，卵巢癌，黑素瘤，中枢神经系统肿瘤，结肠癌和白血病。 构成：抗癌药物组合物包括维生素C，维生素E，顺式维生素A，维生素B，维生素C，其药学上可接受的盐和异构体或其混合物，以及包含它们的葡萄茎壳提取物作为活性成分。 葡萄茎壳提取物是通过提取甲醇，甲醇水溶液，乙醇，乙醇水溶液，丁醇，二氯甲烷，乙酸乙酯或其混合物得到的。 癌症是肺癌，卵巢癌，黑素瘤或结肠癌。 具有癌细胞生长抑制作用的健康增强食品包含维生素C，维生素E，顺式维生素A，维生素B，维生素C，其药学上可接受的盐，异构体或其混合物，以及包含其的葡萄茎壳提取物。 食物是饮料形式。 通过以下步骤获得葡萄茎壳提取物：用甲醇萃取葡萄茎壳，将得到的提取物悬浮于蒸馏水中; 用二氯甲烷分配; 并用乙酸乙酯萃取得到的水层。

公开(公告)号：KR1020120016861A

公开(公告)日：2012-02-27

申请号：KR1020100079356

申请日：2010-08-17

Applicant: 한국화학연구원

Inventor： 김영섭 ,  유시용 ,  홍경식 ,  최춘환 ,  차미란 ,  박우규

IPC: A61K36/65 ,  A61K31/343 ,  A61P25/28 ,  A61P25/00

CPC classification number: A61K36/65 ,  A23L29/035 ,  A23V2200/322 ,  A61K31/216 ,  A61K31/343 ,  A61K2236/33

Abstract: PURPOSE: A pharmaceutical composition containing Paeonia lactiflora seed extract, fraction thereof, or compound isolated from the same is provided to suppress BACE-1 activity and to treat and prevent neurodegenerative diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains Paeonia lactiflora seed extract as an active ingredient. The neurodegenerative diseases include Alzheimer's dieses, Parkinsons's disease, progressive supranuclear palsy. The extract is prepared using water, alcohol of C1-C4, or mixture solvent thereof. The pharmaceutical composition contains Paeonia lactiflora seed fraction as an active ingredient. The pharmaceutical composition also contains compounds as an active ingredient. The method for preparing the compounds comprises: a step of adding water, C1-C3 alcohol, or mixture thereof to the Paeonia lactiflora seeds to prepare Paeonia lactiflora seed extract; a step of fractioning the extract with water, dichloromethane, and ethyl acetate to prepare a fraction; a step of performing silicagel column chromatography of the fraction.

Abstract translation: 目的：提供含有芍药提取物，其部分或从其分离的化合物的药物组合物以抑制BACE-1活性并治疗和预防神经变性疾病。 构成：用于预防或治疗神经变性疾病的药物组合物含有芍药种子提取物作为活性成分。 神经变性疾病包括阿尔茨海默氏病，帕金森氏病，进行性核上性麻痹。 萃取液用水，C1-C4的醇或其混合溶剂制备。 该药物组合物含有作为活性成分的芍药芍药种子。 药物组合物还含有作为活性成分的化合物。 制备化合物的方法包括：将水，C1-C3醇或其混合物加入到芍药种子中以制备芍药提取物的步骤; 用水，二氯甲烷和乙酸乙酯分级提取物以制备级分的步骤; 进行该级分的硅胶柱色谱的步骤。

公开(公告)号：KR101402215B1

公开(公告)日：2014-05-30

申请号：KR1020120088828

申请日：2012-08-14

Applicant: 한국화학연구원 ,  한국생명공학연구원

Inventor： 최정섭 ,  서보람 ,  고영관 ,  김진석 ,  연규환 ,  최춘환 ,  김창진 ,  박동진 ,  주윤정

IPC: C12N1/20 ,  A01N63/02

Abstract: 본 발명은 신규한 균주인 스트렙토마이세스 스코풀리리디스(
Streptomyces

scopuliridis ) KR-001 균주 및 이의 용도에 관한 것으로, 보다 상세하게는 본 발명의 스트렙토마이세스 스코풀리리디스 KR-001 균주, 및 상기 균주, 이의 배양액, 상기 배양액의 추출물, 상기 배양액 또는 추출물의 분획물이 화본과 잡초, 광엽 잡초 및 난방제 잡초에 우수한 살초력을 발휘하여 유용한 잡초 방제제로 사용될 수 있다.

公开(公告)号：KR1020140022586A

公开(公告)日：2014-02-25

申请号：KR1020120088828

申请日：2012-08-14

Applicant: 한국화학연구원 ,  한국생명공학연구원

Inventor： 최정섭 ,  서보람 ,  고영관 ,  김진석 ,  연규환 ,  최춘환 ,  김창진 ,  박동진 ,  주윤정

IPC: C12N1/20 ,  A01N63/02

CPC classification number: A01N63/02 ,  A01N63/00 ,  B01D11/02 ,  C12N1/20 ,  C12R1/465

Abstract: The present invention relates to a Streptomycesscopuliridis KR-001 strain which is a novel strain and to uses thereof. More specifically, the Streptomycesscopuliridis KR-001 strain, a culture broth thereof, extracts of the culture broth, fractions of the culture broth or extracts of the present invention performs excellent herbicidal activities for pots, weeds, broadleafed weeds, and weeds in paddy fields so that the present invention can be used as a weed controller.

Abstract translation: 本发明涉及一种新型菌株及其应用的链霉菌复合菌株KR-001菌株。 更具体地说，本发明的培养液，培养液或提取物的培养液的提取物，培养肉汤，水稻田中的花盆，杂草，阔叶杂草和杂草具有优异的除草活性， 本发明可以用作杂草控制器。

公开(公告)号：KR101338172B1

公开(公告)日：2013-12-09

申请号：KR1020100079356

申请日：2010-08-17

Applicant: 한국화학연구원

Inventor： 김영섭 ,  유시용 ,  홍경식 ,  최춘환 ,  차미란 ,  박우규

IPC: A61K36/65 ,  A61K31/343 ,  A61P25/28 ,  A61P25/00

Abstract: 본 발명에 따른 작약 종자의 추출물, 이의 분획물 또는 이로부터 분리한 화합물은 BACE-1 활성을 저해시켜 알츠하이머형 치매, 파킨슨 병, 진행성 핵상마비 등 퇴행성 뇌질환의 예방 또는 치료에 유용하게 사용될 수 있다.

公开(公告)号：KR1020130083428A

公开(公告)日：2013-07-22

申请号：KR1020130081165

申请日：2013-07-10

Applicant: 한국화학연구원

Inventor： 김영섭 ,  유시용 ,  홍경식 ,  최춘환 ,  차미란 ,  박우규

IPC: A61K31/343 ,  A61K31/045 ,  A61K31/05 ,  A61K36/65

Abstract: PURPOSE: A Paeonia lactiflora seed extract, a fraction thereof, or a compound isolated therefrom, and a pharmaceutical composition containing the same are provided to suppress the activation of beta-secretase (BECE-1) and to prevent or treat neurodegenerative diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains one or more kinds of compounds selected among compounds of chemical formulas 1-8, as active ingredients. A method for preparing the compounds of chemical formulas 1-8 comprises the steps of: adding water, C1-C4 alcohols, or a mixture thereof to Paeonia lactiflora seeds and obtaining a Paeonia lactiflora seed extract; fractioning the extract with water, dichloromethane, and ethyl acetate and obtaining a fraction; and isolating compounds by performing silicagel column chromatography of the fraction and purifying the compounds.

Abstract translation: 目的：提供芍药芍药提取物，其一部分或从其分离的化合物和含有它们的药物组合物以抑制β-分泌酶（BECE-1）的活化并预防或治疗神经变性疾病。 构成：用于预防或治疗神经变性疾病的药物组合物含有选自化学式1-8化合物的一种或多种化合物作为活性成分。 制备化学式1-8的化合物的方法包括以下步骤：将水，C 1 -C 4醇或其混合物加入到芍药芍药种子中并获得芍药提取物; 用水，二氯甲烷和乙酸乙酯分级提取物，得到一部分; 并通过对级分进行硅胶柱色谱法分离化合物并纯化化合物。

公开(公告)号：KR1020130063708A

公开(公告)日：2013-06-17

申请号：KR1020110130221

申请日：2011-12-07

Applicant: 한국화학연구원 ,  주식회사동방아그로

Inventor： 최정섭 ,  고영관 ,  유시용 ,  서보람 ,  최춘환 ,  황인택 ,  이동희 ,  한병수 ,  강광식 ,  엄준원

IPC: A01N65/08 ,  A01P13/00

Abstract: PURPOSE: Juglone is provided to suppress the function of KAPAS(7-keto-8-aminopelargonic acid synthase) which is related to a biotin biosynthesis pathway of microorganisms and plants, significantly control Sicyos angulatus L., and be used as an active ingredient of a safe natural herbicide. CONSTITUTION: A herbicidal composition for controlling Sicyos angulatus L. contains juglone of chemical formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient. Juglone is derived from a black walnut and suppresses KAPAS activity. A method for controlling Sicyos angulatus L. comprises a step of treating Sicyos angulatus L. a seed thereof, or a habitat thereof with the herbicidal composition. The herbicidal composition is used by dipping, spraying or coating.

Abstract translation: 目的：提供Juglone以抑制与微生物和植物的生物素生物合成途径相关的KAPAS（7-酮-8-氨基壬酸合成酶）的功能，显着控制Sicyos angulatus L.并用作活性成分 一种安全的天然除草剂。 构成：用于控制猕猴桃的除草组合物含有化学式1的胡桃醇或其药学上可接受的盐作为活性成分。 Juglone来源于黑胡桃，并且抑制KAPAS的活动。 用于控制ang鱼的方法包括用除草组合物处理其种子或其栖息地的芸香属的步骤。 除草组合物通过浸渍，喷涂或涂布来使用。